Emissions of complex mixtures of polycyclic aromatic hydrocarbons (PAHs) and other compounds into the environment represent a potential threat to the health of humans. Information regarding the dose and duration of exposure is essential to determine the degree of risk and to identify sensitive receptors within a population. Although measurements of chemical concentrations in air may be used to estimate exposures, internal biomarkers provide more accurate information regarding the dose of exposure and retention of toxic chemicals. This study was conducted in a population in rural China exposed to PAHs from a variety of sources. The study population was located in an area known to have an elevated incidence of birth defects. Parents of children born with a neural tube defect (NTD) were recruited as case participants and parents of children born with no visible birth defect were recruited as controls. The study was designed to test the hypothesis that parents of children born with a NTD would exhibit a biomarker of exposure at higher levels than the parents of a child with no visible birth defect. A total of 35 mothers and 32 fathers were recruited as case participants, and 18 mothers and 19 fathers were recruited as control participants. Venous blood was collected from the study participants by hospital staff as soon as possible following the birth of the child. PAHs were isolated from the whole blood by solvent extraction and DNA was isolated from a separate aliquot of blood for 32 Ppostlabeling to measure bulky adducts. Single Nucleotide Polymorphisms (SNPs) in phase II enzymes were also monitored in an attempt to identify sensitive receptors. Both total and carcinogenic PAH (cPAH) concentrations were elevated in the parents of case children. Both values were elevated significantly in mothers, whereas only cPAH concentrations were elevated significantly in fathers. Levels of DNA adducts were highly variable and displayed a reverse pattern to that of PAH levels in blood. None of the polymorphisms evaluated were correlated with PAH levels or DNA adducts. For mothers, whose total PAH concentration was above the median concentration, the age-adjusted odds ratio (OR) for having a child with a NTD was 8.7. Although this suggests that PAHs may be a contributing factor to the risk of NTDs, the lack of a correlation with DNA adducts would suggest a possible non-genotoxic mechanism. Alternatively, the PAHs may be a surrogate for a different exposure that is more directly related to the birth defects. The results have shown that blood levels of PAHs may be used to identify populations exposed to elevated concentrations of combustion by-products.
Introduction
Humans are constantly exposed to hazardous chemicals. These chemicals are usually mixtures and may contain hundreds of different components. Often, complex mixtures include components that are known to be toxic to human or ecological receptors and others with a less well-characterized toxicity. Polycyclic aromatic hydrocarbons (PAHs), a class of chemicals produced from the incomplete combustion of organic substances, such as coal, gas, wood, or tobacco, are one of the most common complex mixtures in the environment. Several PAHs have been classified as carcinogens by the US. Environmental Protection Agency (USEPA) (USE-PA, 2006 ) and the International Agency for Research on Cancer (IARC, 2004) . Epidemiological studies on populations exposed to PAH mixtures have shown a link between these exposures, and cancers of the lung, respiratory system, and stomach (Bertrand et al., 1987; Puisieux et al., 1991; Krewski and Thomas, 1992; Vyskocil et al., 2004) . Smoking and exposure to environmental tobacco smoke (ETS) have been shown to be associated with cancer in the lung, bronchus, larynx, bladder, cervix, and oral mucosa (Phillips, 1997; Lee et al., 2006; Yach and Wipfli, 2006) . PAH exposure levels are classically estimated by air sampling. Air sampling provides valuable information regarding environmental concentrations and potential human exposures. However, air sampling does not provide information regarding internal dose. Internal dose may be quantified by the determination of a parent compound or metabolite in body fluids such as blood or urine. Biological effects, as a measure of internally effective dose, are considered more relevant for the assessment of the ultimate human health risk. These effects are monitored by biochemical markers, including covalent binding products to DNA or proteins in addition to DNA strand breaks, or cytogenetic markers, such as micronuclei, chromosome aberrations, and sister chromatid exchange (van Delft et al., 2001) . DNA adducts are considered as a marker for potential risk of genotoxic effects, which might lead to undesirable outcomes, such as cancer or birth defects. DNA adducts may also reflect individual variations in exposure, absorption, metabolic activation, and DNA repair. The estimated half-life of DNA adducts was reported to be approximately 3-4 months (Mooney et al., 1995) . Hemminki et al. (1990a, b) monitored DNA adducts and PAH exposures in coke oven workers in Poland. Two control groups were recruited to the study. One group consisted of local residents who lived in the area, but were not coke oven workers. The second control group consisted of rurally residing non-coke oven workers. Unexpectedly, DNA adduct concentrations in the local controls were nearly as high as the levels detected in the coke oven workers. However, the adduct levels in the rural controls were two to three times lower than those of the coke oven workers, as expected. The authors suggested that DNA adduct levels in those non-coke oven workers who lived in the surrounding area were similar to the concentrations measured in the coke oven workers as a result of environmental pollution in the area. The authors noted that this locality is a highly industrialized region, with a large population and the presence of many coal mines, smelters, and chemical plants.
The authors also noted that the common practice of domestic coal burning may have also been a source of exposure for the local residents. DNA adducts measured by 32 P-postlabeling in WBCs of a non-smoking group of women who work outdoors in a polluted city in the Czech Republic was associated with their personal PAH exposure (Binkova et al., 1995) . In a more recent study, Peluso et al. (2008) studied the genotoxic effects of air pollutant exposures on a human population living downwind to an industrial complex in Thailand. Their findings revealed that the level of bulky DNA adducts in the leukocytes of residents was 0.85 ± 0.07 per 10 8 nucleotides, which was significantly elevated compared with the residents living in a control district.
Many studies on environmental exposures to PAHs in humans focus on air pollution. Epidemiological studies indicate that exposures to PAHs in air are associated with increases in mortality and/or morbidity from respiratory illnesses, cardiovascular diseases, cancer (Taioli et al., 2007) , and adverse birth outcomes. Nielsen et al. (1996) observed a relative risk for lung cancer of 1.5 in an urban community exposed to air pollution. Airborne PAHs have been implicated in human reproductive effects, notably DNA adducts and hypoxanthine-guanine phosphoribosyltransferase mutations in newborns, as well as preterm birth and intrauterine growth restriction (Sra´m et al., 1999; Dejmek et al. 2000; Perera et al. 2002) . Findings from a more recent study suggest that high levels of PAHs, as measured by DNA adducts in cord blood from the World Trade Center fires in New York City in 2001, may have contributed to reduced fetal growth in exposed women (Perera et al. 2005) . In a review of the literature on ambient pollution and pregnancy outcomes by Sra´m et al. (1999) , low birth weight, premature birth, and intrauterine growth retardation seemed to be the reproductive effects most often associated with air pollutants. The study observed that intrauterine growth retardation was specifically linked with PAHs. A potential link between coal combustion by-products and the risk of congenital malformation was investigated by a study conducted in Nova Scotia, Canada. In this study, the risk of congenital malformations (overall and specific categories) was increased in the offspring of the residents of a coking operation, compared with the rest of Nova Scotia (Dodds and Seviour, 2001 ). On the other hand, a recent report (Shaw et al. 2009) suggests that maternal smoking, measured with cotinine levels during mid-pregnancy, was possibly associated with reduced risks of neural tube defects (NTDs).
Single nucleotide polymorphisms (SNPs) that alter the activity of metabolizing or DNA repair enzymes are also assumed to alter the formation of DNA adducts. Several studies have noted a lack of significant difference in lymphocyte PAH-DNA adduct levels between GSTM1-deficient and -proficient individuals (Ryberg et al., 1994; Hou et al., 1995; Binkova et al., 1998) . However, findings reported by Georgiadis et al. (2004) indicate that nonsmoking students exposed to urban air pollution and ETS with GSTM1 deletion had higher levels of DNA adducts in their lymphocytes compared with GSTM1 ''wild-type'' participants. Never-smoking women with GSTM1 null had statistically significant greater risk of developing lung cancer from exposure to ETS (Bennett et al., 1999) . Lung cancer risk in GSTM1-null individuals exposed to indoor coal combustion emissions was elevated compared with individuals with an active copy of GSTM1. GSTT1 polymorphisms, on the other hand, did not seem to be associated with lung cancer risk (Lan et al., 2000) . However, individuals with null genotypes of GSTT1 seemingly had an increased risk for developing colorectal cancers (Deakin et al., 1996) . The inactive GSTT1 genotype was also associated with increased risk in some forms of brain tumors (Hand et al., 1996; Kelsey et al., 1997) .
In an earlier report, elevated levels of genotoxic mixtures of PAHs were detected in the residential environments of a population located in Shanxi province, China (Naufal et al., 2007) . The study described in this paper was directed at the analysis of biomakers of exposure, effect, and susceptibility in parents of children born with NTDs, and their matched controls. As a measure of internal dose of PAHs, PAH concentrations in whole blood were quantified. The frequency of aromatic DNA adducts was measured by 32 Ppostlabeling technique in WBCs from recruited participants as an indicator of internal effective dose. Polymorphisms of two main phase II metabolic enzymes (GSTM1, GSTT1) were also monitored to evaluate the influence of genetic sensitivities.
Methods

Study Site
Four counties (Taigu, Pingding, Xiyang, and Zezhou) in Shanxi province in northern China were selected for this research as it was anticipated that elevated concentrations of PAHs were present in their environment. Shanxi is located approximately 200 miles Northwest of Beijing. ShanxiFknown as the ''Coal Warehouse of China''Fis the leading province in coal production in China and provides as much as one quarter of China's coal. The coal mined from this region is most often used indoors for cooking and heating. Residents in Shanxi may be continuously exposed to PAHs and other by-products by either inhalation of the airborne soot particles or ingestion of soot particles that deposit on food. The incidence of NTDs in Shanxi is one of the highest in the world. There is concern regarding the impact of PAH exposures on health because the overall prevalence rate for NTDs in China is 1.3/1000 live births; whereas in the Northern part of the country (where this study was conducted), the rate is 2/1000 births (Dai et al., 2002) . In comparison, the estimated NTD prevalence in the United States, based on birth certificate data for 1995, was 0.4/1000 (Mathews et al., 2002) .
Participant Recruitment
This study focused on parents of children with congenital abnormalities because it was believed that these may represent a segment of the population sensitive to PAH exposures. Study participants included parents of children born with a NTD and parents of children born with no visible abnormality at the same hospital and conceived at approximately the same time to serve as a control group. A control was recruited as the first baby to be born with no visible malformation within 48 h of a case recruitment in the same hospital. Participants were recruited for participation in the study throughout the year at four county hospitals in Taigu, Pingding, Xiyang, and Zezhou. The combined annual number of births at these four hospitals was on average more than 3000; prevalence rates for NTDs in the four hospitals ranged from approximately 8/1000 to 24/1000. Overall, NTDs did not seem to exhibit seasonal variations.
The types of congenital malformations that were studied were selected on the basis of evidence suggesting an environmental component in their etiology. Neural tube defects, including anencephaly and spina bifida, are readily recognizable at birth based on a routine newborn physical examination. Participant recruitment was facilitated by the presence of a birth defects surveillance system in China since 1992 as described by Li et al. (2003) . All recruited participants were informed of the nature of the study, and signed consent forms approved by the Texas A&M University Institutional Review Board (IRB no. 2003-0430) . Mothers who provided informed consent to enroll in the study were interviewed in person using a standardized questionnaire that was translated to Chinese. The questionnaire was designed to obtain information relevant to potential risk factors and confounders that are relevant to the circumstances in China.
Sample Collection
Venous Blood Samples Venous blood samples were collected at the hospital by the medical staff and stored at 41C before transporting them to the Peking University Health Science Center in Beijing, China. A volume of 10-15 ml of venous blood was collected in sodium heparin BD Vacutainer tubes (VWR, catalogue no.VT6480) from study participants. Samples were stored at appropriate temperatures to be shipped on refrigerant gel packs to Texas A&M University for processing and analysis. Shipment of samples was carried out according to the regulations of the US Department of Transportation and International Air Transport Association.
Sample Extraction and Chemical Analysis
Extraction of Venous Blood Venous blood samples were centrifuged in the heparinized collection tubes at 3000 RPM for 10 min. This procedure served to separate the blood into an upper lighter plasma layer and a lower denser cell layer. The plasma layer was transferred by pipette to borosilicate glass vials to store at À801C for PAH extraction and analysis. The cell layer was stored in the original blood collection tubes at 41C for DNA isolation.
A modified version of the method described in the USEPA Manual of Analytical Methods for the Analysis of Pesticides in Human and Environmental Samples (Watts, 1980) was used to extract PAHs from the plasma using a liquid-liquid extraction. A volume of 2 ml of plasma was used. Surrogates consisting of deuterated PAHs, such as naphthalene, acenaphthylene, phenanthrene, chrysene, and perylene, were added before sample extraction. The plasma was thawed and subsequently mixed with methanol (1:2 v/v) to denature plasma proteins. Samples were then sonicated thrice for 1 minute at approximately 5-minute intervals. A break during sonication was needed to prevent heating of the samples. Samples were then decanted into separatory funnels, and 10 ml of dichloromethane was added to begin the extraction process and to rinse each sample vial. Plasma samples were then extracted thrice with 20 ml of dichloromethane. Each extract was shaken for 3 min with a 20-min settling period. The combined extracts were filtered on a solid phase extraction column (Restek, Bellefonte, PA, USA) that contained a layer of combusted sodium sulfate. The volume of the extract was reduced to 2-3 ml before chemical analysis.
Chemical Analysis A modified USEPA SW-846 Method 8270C (USEPA, 1996) was used for the quantitative determination of PAHs and their alkylated homologs in extracts of biological tissue. This method was developed for PAH quantitation and was described earlier (Cizmas et al., 2003) . Analysis was conducted on a Hewlett-Packard 5890 Series II gas chromatograph with a 5972 mass selective detector in selected ion monitoring mode. A 60 m Â 0.25 mm ID Â 0.25 mm film thickness DB-5MS column (Agilent Technologies, Palo Alto, CA, USA) was used. The injection port was maintained at 3001C and the transfer line at 2801C. The temperature program was as follows: 601C for 6 min increased at 121C/min to 1801C, then increased at 61C/min to 3101C and held for 11 min for a total run time of 47 min. The method limit of detection (MDL) for benzo [a] pyrene (B(a)P) in blood was estimated at 2.95 ng/ml. Recovery of surrogates was between 40% and 110%.
DNA Isolation and
32 P-Postlabeling DNA isolation from WBCs was conducted as described earlier (Gupta, 1984; Binkova et al., 2000) . DNA concentration and purity were measured spectrophotometrically by absorbances at 260 and 280 nm. The A 260 /A 280 ratio for all samples was between 1.6 and 1.8. The nuclease P1-enhanced bisphosphate version of the 32 P-postlabeling assay was performed as described by Reddy and Randerath (1986) . Briefly, 10 mg of DNA was enzymatically digested to normal (Np) and modified (Xp) deoxyribonucleoside 3 0 -monophosphates. After 3 0 -dephosphorylation of normal nucleotides with nuclease P1, the enriched nuclease P1-resistant modified 3 0 -nucleotides were converted to 5 0 -32 P-labeled deoxyribonucleoside 3 0 and 5 0 -bisphosphate derivatives (pXp) by incubation with carrier-free [g-32 P] ATP and T4 polynucleotide kinase. Adducted radioactive nucleotides were separated by multidirectional anion-exchange thin-layer chromatography (TLC) using polyethyleneimine-cellulose sheets. Labeled products were purified and partially resolved by onedimensional development with 2.3 M NaH 2 PO 4 , pH 5.75 overnight (D1). Bulky labeled adducts retained in the lower (2.8 Â 1.0 cm) part of the D1 chromatogram were contacttransferred to fresh thin-layer sheets and resolved by twodimensional TLC. The first dimension employed 3.82 M lithium formate þ 6.75 M urea, pH 3.35. The second dimension was developed with 0.72 M NaH 2 PO 4 þ 0.45 M TRIS þ 7.65 M urea, pH 8.2. Radioactivity of each TLC map was determined by using an Instant Imager (Packard Instrument, Downers Grove, IL, USA). DNA adduct levels were quantified as mean relative adduct labeling (RAL) values ± SD using the following equation:
RAL ¼ sample count rate=ðDNA ÀPÂspecific activity ATP Þ where the sample count rate is measured in cpm, DNA-P represents the pmol of DNA monomer units assayed per replicate, and the specific activity of the ATP is in units of cpm/pmol.
Genotyping
DNA from WBC samples was genotyped for null deletions in GSTM1 and GSTT1 using the methods described by Bailey et al. (1998) . PCR was used to amplify and assay the GSTM1 and GSTT1 alleles. The products were digested with the restriction enzymes HinfI and NcoI, electrophoresed, and visualized using ethidium bromide staining. The genotyping call rate was about 99.6%.
Statistical Analyses
Statistical analyses were performed using SigmaStat (version 3.1) software package. Multivariate analyses were performed by using Student's t-test or one-way Analysis of Variance (ANOVA) unless the normality test failed (Po0.05). When normality failed, Mann-Whitney Rank Sum Test or KruskalWallis one-way ANOVA on Ranks was carried out. Pearson's coefficient was computed to assess bivariate correlations. The criterion for statistical significance was set at Po0.05. w 2 and Fisher's exact tests were used to compute a crude odds ratio (OR) and 95% confidence interval (CI). The age-adjusted OR was calculated using logistic regression, including maternal age as a covariate in the model, with the outcome being a NTD case versus a normal birth as a control.
Results
Venous blood was collected from mothers and fathers of children born with a NTD, and parents of a matched control child. Samples were collected from a total of 53 mothers and 51 fathers. Among the mothers, 35 delivered a baby with a NTD and 18 delivered visibly normal babies, and were recruited as controls. Among the fathers, 32 were the parents of a baby with a NTD and 19 were fathers of visibly normal children. None of the mothers reported to be a smoker. However, 27 (18 cases, 9 controls) of 53 mothers reported being exposed to passive cigarette smoke. The majority of the mothers were aged between 25 and 35 years. Among the fathers, 38 (25 cases, 13 controls) of 51 reported smoking, at least occasionally. The characteristics of the study population are summarized in Table 1 .
As a measure of internal dose, extracts of venous blood samples from mothers and fathers were chemically characterized for 60 PAH congeners. The chemicals quantified in blood included low and high molecular weight PAHs, in addition to their alkylated homologs. The seven PAHs classified by the USEPA as class B2 carcinogens were also included in the analysis. The mean level of total PAHs (tPAHs) detected in venous blood from mothers of cases (258 ng/ml) was significantly higher than that detected in venous blood from control mothers (120 ng/ml) ( Table 2) . Venous blood from case fathers was found to have mean PAH levels of 217 ng/ml, whereas mean PAH levels of 159 ng/ml were detected in blood from control fathers. However, this difference was not statistically significant.
The seven USEPA class B2 carcinogenic PAHs (cPAHs)F benz(a)anthracene, chrysene, benzo(b)fluoranthene, benzo(k)fluoranthene, B(a)P, indeno(1,2,3-c,d)pyrene, and dibenzo(a,h)anthraceneFwere also quantified in venous blood samples from parents of case and control children. Mean levels of cPAHs were significantly elevated in case mothers (19 ng/ml) when compared with control mothers (9 ng/ml). Among fathers, those with case children had mean cPAH levels of 15 ng/ml, whereas the concentration of cPAHs in venous blood from fathers of control children was 10 ng/ml. The cPAH levels in case fathers were also statistically elevated in comparison with control fathers. The data on cPAHs among case and control mothers, as well as case and control fathers are presented in Figure 1 .
Although none of the mothers smoked, 27 mothers reported being exposed to passive cigarette smoke. Mothers exposed to passive smoking (occasional or daily) had mean levels of tPAHs and cPAHs in their blood of 233 and 16 ng/ ml, respectively. Non-smoking mothers who reported no exposure to passive smoking had mean levels of 188 ng/ml tPAHs and 15 ng/ml cPAHs. However, these differences were not statistically significant.
Smoking among fathers was very common (38/51) and included a range of participants from occasional smokers to individuals who smoked more than 20 cigarettes per day. Fathers were separated into two subsets by smoking status to detect any difference in the tPAH and cPAH levels among smokers and non-smokers. Non-smoking fathers had mean tPAH levels of 236 ng/ml in their venous blood compared with 182 ng/ml for smokers, but the difference was not statistically significant. The exposures in mothers and fathers were further evaluated. A linear regression was analyzed to investigate the possible correlation between tPAH levels in blood from paired fathers and mothers (Figure 2a) . A correlation that was statistically significant was detected (correlation coefficient (r) ¼ 0.408; Po0.05). In addition, a linear regression of the levels of blood tPAHs in paired non-smoking fathers and mothers revealed a stronger statistically significant correlation (r ¼ 0.662; Po0.05) (Figure 2b) .
The association between having a baby with a NTD and maternal PAH exposure level was examined. Mothers were divided into two groups, a high exposure group and a low exposure group, according to their median blood PAH level (206 ng/ml). Mothers with high PAH exposures were found to have a significantly higher risk compared with the lower exposure group (OR 10.91; 95% CI: 2.61-45.60). The ageadjusted model did not change the increased risk of NTDs among mothers (OR 8.70; 95% CI: 2.02-37.04) ( Table 3) .
Bulky DNA adducts were analyzed by 32 P-postlabeling in WBCs as a biomarker of genetic damage. Control parents exhibited significantly higher levels of DNA adducts as compared with case parents. Figure 3 displays bar graphs representing mean DNA adduct levels detected in WBCs of mothers. Mean level of DNA adducts in case mothers was 12.19 per 10 9 normal nucleotides compared with 17.13 per 10 9 nucleotides in controls. Similarly, mean level of DNA adducts in case fathers was 10.97 per 10 9 nucleotides, which was significantly lower than 20.64 per 10 9 nucleotides, the mean level of bulky DNA adducts in control fathers. Smoking status did not seem to influence the levels of DNA adducts in the study participants.
The variable that seemed to have the greatest impact on DNA adduct levels in mothers was the type of fuel used for cooking. Mothers reported using types of hard coal, black coal, firewood, and natural gas as cooking fuels. Hard coal seems to be the most abundantly used cooking fuel. When DNA adduct levels in WBCs of mothers who used hard coal as a cooking fuel were compared with those who use another type of cooking fuel, they seemed significantly elevated. In fact, mean levels of DNA adducts in WBCs of mothers using hard coal were 15 per 10 9 nucleotides which was significantly elevated compared with 11 adducts per 10 9 nucleotides, the mean level found in WBCs of mothers using other types of Abbreviations: CI, confidence interval; OR, odds ratio.
a High exposure was defined as a blood total PAH level greater than the median (206 ng/ml); low was defined as a blood PAH level lower than the median. cooking fuel. These data are graphically represented in Figure 4 .
Genotyping of two major phase II metabolic enzymes, GSTM1 and GSTT1, revealed that the GSTM1 deletion rate was of 26% in mothers and 19% in fathers, whereas GSTT1-null genotype was found in 19% of the mothers and 19% of the fathers. The effect of having an inactive copy of GSTM1 or GSTT1 was evaluated by computing ratios of PAH levels in blood to levels of bulky DNA adducts in study participants, combining data from fathers and mothers. The assumption was that an inactive form of GSTM1 or GSTT1 might slow down the elimination of PAH compounds and thereby increases the likelihood of DNA adduct formation by these chemicals. Thus, the ratio of DNA adduct to PAH blood level in individuals with non-functional GSTM1 or GSTT1 was expected to be higher than in individuals with a functional copy of these enzymes. Further, individuals were grouped by exposure level as determined by their cPAH blood levels. High exposure level was defined as cPAH higher than the median, whereas lower exposure level was defined as a cPAH level lower than the median. In the low exposure group, the mean ratio detected in GSTM1-null individuals (6.07) was higher than that in GSTM1 wild-type individuals (4.02), achieving marginal statistical significance (Po0.1). In the high exposure group, the same trend was observed, however, without statistical significance. The results were reversed across GSTT1 polymorphisms, without being statistically significant. These data are presented in Table 4 .
Discussion
The goal of this study was to collect biological samples to evaluate two different methods for measurements of biomarkers in a population exposed to combustion by-products. Data were collected to test the hypothesis that the mothers or fathers of children born with a NTD would exhibit a biomarker of exposure at higher levels than the parents of a child with no visible birth defect. A total of 53 mothers (35 cases and 18 controls) and 51 fathers (32 cases and 19 controls) were recruited to participate in the study. Earlier studies have observed elevated rates of birth defects in the provinces where the participants were recruited (Li et al., 2006; Gu et al., 2007) . It was also anticipated that the population has multiple sources of exposure to PAHs, including ingestion of cooked foods, inhalation of coal combustion by-products, as well as active and passive smoking (in approximately half the population). Any chemical at a certain dose level can arguably induce teratogenic effects. During early pregnancy, when organs are developing, the fetus is especially vulnerable. Maternal chemical exposures can, therefore, significantly affect fetal development by compromising placental development and exchange, as well as hormonal signaling needed for in utero fetal growth (Miller et al. 2004) . PAHs can affect in utero fetal development by binding to the aryl hydrocarbon receptor (AhR) causing anti-estrogenic activity, through increased metabolism and depletion of endogenous estrogens, (Carpenter et al. 2002) thus disrupting the endocrine system by altering steroid function. In addition, PAH binding to receptors for placental growth factors may result in an impairment of the feto-placental oxygen and nutrient exchange (Dejmek et al. 2000) leading to fetotoxicity.
The data were collected from case and control parents for two biomarkers. Concentrations of total and carcinogenic PAHs were used to provide information on total exposures to combustion by-products. Measurement of DNA adducts were used to provide a biomarker of genotoxic effects. The incidence of DNA adducts is believed to be affected both by total exposure, as well as genetic factors that influence retention of PAHs and repair of DNA adducts. The results confirmed significant differences in biomarkers between case and control participants. Specifically, both total and cPAHs were significantly higher in blood from case mothers when compared with control mothers. For fathers, 75% of whom report smoking, there was no significant difference in tPAH levels between case and control participants. However, cPAHs were significantly higher in the case fathers. The correlation between the levels of tPAHs in the blood of paired fathers and mothers suggests the presence of a common source of exposure. When adjusted for smoking, the correlation became more pronounced indicating further that the source of PAHs is primarily environmental. Indoor coal combustion seems to be the chief source of PAH exposure in the study population.
Results from other studies, which investigated the levels of PAHs in blood for comparison purposes, are limited. Singh et al. (2008) evaluated nine individual PAHs in the blood of an Indian population. In addition, Neal et al. (2008) evaluated four specific PAHs in a Canadian population. This work presented a total of approximately 60 analyzed PAH congeners (low-and high-molecular weight PAHs, and alkylated homologs). As the PAH data are presented differently, direct comparison of quantified values is not possible. However, results from a similar biomarker study currently evaluating a similar panel of PAHs in a population living near a hazardous waste site in Sumgayit, Azerbaijan, indicate that the levels of blood PAHs in study participants are similar to those found in our study participants in China (unpublished data).
Bulky DNA adducts exhibited a reversed trend and were significantly higher in both parents of controls as compared with NTD cases. This trend suggests a potential nongenotoxic mechanism of PAHs in the etiology of NTDs. An earlier report indicated that PAHs are potentially capable of inducing estrogenic and anti-estrogenic responses in humans mediated by the activation of the estrogen receptor (ER) (Santodonato, 1997) . Recent studies provided further experimental evidence that PAHs, more specifically B(a)P and 3-methylcholanthrene, in addition to being AhR agonists can also bind and activate ERa independently of AhR Liu et al., 2006) . Organic extracts primarily consisting of polycyclic aromatic compounds, isolated from road dust and diesel exhaust particulates, were found to contain contaminants that induced significant ER ligand activity (Misaki et al., 2008) . Nevertheless, further research is needed to better understand these relatively less documented mechanisms of PAH toxicity and their effects on living organisms. Alternatively, the PAHs may serve as surrogate markers for exposures to other components of combustion by-products (e.g., arsenic) and thus a genotoxic biomarker was not induced in the parents of children with a birth defect. Arsenic has been linked with NTDs in animal studies (ATSDR, 2007) . However, limited measurements of arsenic in coal and drinking water in this region have not indicated elevated concentrations of arsenic (unpublished data).
Other explanations for the lack of correlation between PAH levels in blood and DNA adducts include the fact that DNA adducts were analyzed in total leukocytes as opposed to specific long-lived WBCs, which might lead to a dilution effect in DNA adduct levels. Route of exposure may also affect DNA adduct concentrations detected in WBCs. Specifically, adduct levels following inhalation exposure (the main route of exposure in this study) may be lower than levels detected following oral or dermal exposure. In addition, the non-cPAHs may have altered metabolism of the cPAHs and thus reduced the formation of DNA adducts. Studies of complex PAH mixtures in animals suggest that this type of inhibitory effect of PAH mixtures is common (ATSDR, 1995) .
Cooking using hard coal seemed to have the greatest influence on increasing the levels of DNA adducts in mothers. The use of solid fuel for cooking was associated earlier with an increased risk of lung cancer in Europe (Lissowska et al., 2005) . In China, cooking frequency was associated with higher levels of urinary 1-hydroxypyrene in females as well as males .
Deletions in two major phase II metabolic enzymes GSTM1 and GSTT1 were evaluated as a measure of genetic sensitivity in this population. Individuals with inactive copies of GSTM1 exhibited higher ratios of DNA adducts to cPAH blood levels compared with those with active forms of these enzymes. Evaluation of genetic variations in additional genes is warranted for better understanding of the genetic sensitivities present in the study population.
In conclusion, the presence of genotoxic PAH compounds was confirmed in biological tissues sampled from a human population located in a rural area of China. One limitation of this investigation is the sample size and the limited number of controls per case. Results from this work are preliminary and should be confirmed in a larger-scale study. Mothers of newborn children with a NTD exhibited elevated levels of PAHs in their blood as compared with controls. A relationship between the ratios of DNA adducts to exposure and single nucleotide polymorphisms in phase II enzymes was observed. Although data were not obtained to identify a mechanism to associate the PAH exposures with the birth defects, the results suggest that it is seemingly not associated with a genotoxic response as measured by DNA adducts. 
